Literature DB >> 937959

Tissue culture of human adult adenoids and of middle eear mucosa.

Z Weisman, J Sadé.   

Abstract

The increased number of mucus producing cells as well as the presence of stratified squamous epithelium in pathological and experimental middle ear conditions, point towards the possibility of metaplastic changes of the middle ear mucosa, similar to the metaplastic capabilities of respiratory mucosae in general, as observed clinically or provoked experimentally. The purpose of this study was to develop a model of postembryonic human respiratory mucosae, in vitro, for the study of triggering or inducing factors involved in its normal and metaplastic differentiation. Explants from adenoids and middle ear mucosa were cultured, both as organ cultures and monolayers, for periods of up to two weeks, and their developmental characteristics were studied and described. Over 50% of the explants showed mitosis, epithelial and monolayer growth, ciliary activity and differentiation into ciliated and into mucus-producing cells. Adenoid explants were grown in air without and with added 5% CO2. Under the latter conditions, the proportion of explants and monolayers showing ciliary activity was 50% greater. It is concluded that this model might be suitable for further studies of the factors which control cyto-differentiation in mucociliary epithelia. Maintaining its growth for a longer period would, however, be desirable.

Entities:  

Mesh:

Year:  1976        PMID: 937959     DOI: 10.1177/000348947608500303

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  2 in total

1.  [The reactions of human middle ear mucous membrane (author's transl)].

Authors:  W Arnold
Journal:  Arch Otorhinolaryngol       Date:  1977-04-20

2.  Epithelial cell culture from human adenoids: a functional study model for ciliated and secretory cells.

Authors:  Claudia González; Marisol Espinosa; María Trinidad Sánchez; Karla Droguett; Mariana Ríos; Ximena Fonseca; Manuel Villalón
Journal:  Biomed Res Int       Date:  2013-02-05       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.